Franco Cavaleri, B.Sc., Ph.D.c, a distinguished biomedical research scientist and CEO of Biologic Pharmamedical Research and ...

Doctor reveals the best alternatives to surgery for chronic joint pain; shares 8 game-changing treatments, therapies, diet ...

At this week’s International Conference on Alzheimer’s and Parkinson’s Diseases and Related Neurological Disorders, researchers from Suntec Medical Inc. and collaborators presented a poster ...

NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical company committed to discovering and developing novel, first-in-class and best-in-class therapies to treat cancer, today announced ...

The European Commission (EC) has approved ustekinumab for the treatment of moderately to severely active Crohn’s disease in ...

So why do so many life-forms breathe oxygen? There are probably thousands of kinds of metabolisms, or chemical processes that ...

The fierce debate about smartphones and adolescent mental health rests on conflicting science. Researchers and technology companies must work to improve it.

Discover how Danaher refocuses on life sciences with strong fundamentals and strategic growth, despite near-term challenges.

Expert Rev Pharmacoeconomics Outcomes Res. 2012;12(3):319-333. The most recent biologic therapy to receive marketing approval, tocilizumab, was evaluated in a 24-week, randomized, placebo ...